Using Design Thinking to Differentiate Useful From Misleading Evidence in Observational Research

被引：55

作者：

Goodman, Steven N. ^{[1
]}

Schneeweiss, Sebastian ^{[2
]}

Baiocchi, Michael ^{[3
,4
]}

机构：

[1] Stanford Univ, Dept Med, Sch Med,Dept Hlth Res & Policy,Div Primary Care &, Meta Res Innovat Ctr Stanford METRICS,Div Epidemi, Stanford, CA 94305 USA

[2] Harvard Med Sch, Brigham & Womens Hosp, Div Pharmacoepidemiol, Dept Med, Boston, MA USA

[3] Stanford Univ, Dept Med, Sch Med, Stanford Prevent Res Ctr,Dept Stat, Stanford, CA 94305 USA

[4] Stanford Univ, Sch Med, Div Epidemiol, Stanford, CA 94305 USA

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2017年 / 317卷 / 07期

基金：

美国国家卫生研究院; 美国医疗保健研究与质量局;

关键词：

BIAS; RISKS;

D O I：

10.1001/jama.2016.19970

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：705 / 707

页数：3

共 21 条

[1] Adjusted Analyses in Studies Addressing Therapy and Harm Users' Guides to the Medical Literature [J].

Agoritsas, Thomas ;

Merglen, Arnaud ;

Shah, Nilay D. ;

O'Donnell, Martin ;

Guyatt, Gordon H. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (07) :748-759

[2] Evaluating short-term drug effects using a physician-specific prescribing preference as an instrumental variable [J].

Brookhart, MA ;

Wang, PS ;

Solomon, DH ;

Schneeweiss, S .

EPIDEMIOLOGY, 2006, 17 (03) :268-275

[3] Sensitivity Analysis Without Assumptions [J].

Ding, Peng ;

VanderWeele, Tyler J. .

EPIDEMIOLOGY, 2016, 27 (03) :368-377

[4] Stroke, Bleeding, and Mortality Risks in Elderly Medicare Beneficiaries Treated With Dabigatran or Rivaroxaban for Nonvalvular Atrial Fibrillation [J].

Graham, David J. ;

Reichman, Marsha E. ;

Wernecke, Michael ;

Hsueh, Hui ;

Izem, Rima ;

Southworth, Mary Ross ;

Wei, Yuqin ;

Liao, Jiemin ;

Goulding, Margie R. ;

Mott, Katrina ;

Chillarige, Yoganand ;

MaCurdy, Thomas E. ;

Worrall, Chris ;

Kelman, Jeffrey A. .

JAMA INTERNAL MEDICINE, 2016, 176 (11) :1662-1671

[5] Design and analysis choices for safety surveillance evaluations need to be tuned to the specifics of the hypothesized drug-outcome association [J].

Gruber, Susan ;

Chakravarty, Aloka ;

Heckbert, Susan R. ;

Levenson, Mark ;

Martin, David ;

Nelson, Jennifer C. ;

Psaty, Bruce M. ;

Pinheiro, Simone ;

Reich, Christian G. ;

Toh, Sengwee ;

Walker, Alexander M. .

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 (09) :973-981

[6] Does obesity shorten life?: The importance of well-defined interventions to answer causal questions [J].

Hernan, M. A. ;

Taubman, S. L. .

INTERNATIONAL JOURNAL OF OBESITY, 2008, 32 (Suppl 3) :S8-S14

[7] Observational Studies Analyzed Like Randomized Experiments An Application to Postmenopausal Hormone Therapy and Coronary Heart Disease [J].

Hernan, Miguel A. ;

Alonso, Alvaro ;

Logan, Roger ;

Grodstein, Francine ;

Michels, Karin B. ;

Willett, Walter C. ;

Manson, JoAnn E. ;

Robins, James M. .

EPIDEMIOLOGY, 2008, 19 (06) :766-779

[8] New "21st Century Cures" Legislation Speed and Ease vs Science [J].

Kesselheim, Aaron S. ;

Avorn, Jerry .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (06) :581-582

[9] Good practices for quantitative bias analysis [J].

Lash, Timothy L. ;

Fox, Matthew P. ;

MacLehose, Richard F. ;

Maldonado, George ;

McCandless, Lawrence C. ;

Greenland, Sander .

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2014, 43 (06) :1969-1985

[10]

Leamer E. E., 1978, SPECIFICATION SEARCH, V53

← 1 2 3 →